The National Institutes of Health (NIH) has quietly added ivermectin to their list of antiviral therapies for their COVID-19 treatment guidelines.
“Ivermectin is an antiparasitic drug that is being evaluated to treat COVID-19,” the NIH states on their website, although they note that “ivermectin is not approved by the FDA for the treatment of any viral infection.”